Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Level of Blood Brain Barrier Damage Biomarker Predicting Hemorrhagic Transformation Following Acute Ischemic Stroke

NCT05321225 is registered in ClinicalTrials.gov with Ji Xunming,MD,PhD as lead sponsor.

NCT NCT05321225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Level of Blood Brain Barrier Damage Biomarker Predicting Hemorrhagic Transformation Following Acute Ischemic Stroke
Lead sponsor
Ji Xunming,MD,PhD
Phase
Observational
Overall status
Unknown status
Start date
March 10, 2022
Completion date
December 31, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke